Franklin v. JANSSEN RESEARCH & DEVELOPMENT LLC f/k/a JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT LLC et al | Search

Accessibility help Skip to navigation Skip to content Skip to footer

Showing results for Franklin v. JANSSEN RESEARCH & DEVELOPMENT LLC f/k/a JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT LLC et al

Sort by

Viewing results 1‒25 of 39189

Biotech
Healthcare investor looks to cash in on pharma outsourcing trend with €1bn-plus sale
...It has also worked on drug development for US pharma company Johnson & Johnson, Danish biotech group Genmab and British biotech Iksuda therapeutics....
March 3, 2024
Biotech
Japan’s development bank makes first UK life sciences investment
...Japan’s sovereign development bank is investing in UK life sciences for the first time with funding for 4Bio Capital, a UK venture fund that backs advanced treatments such as cell and gene therapies....
January 4, 2024
FT Live
US Pharma and Biotech Summit
Strategies for innovation, pricing and access
Thursday, 16 MayNew York, NY, USA
Novo Nordisk AS
Novo Nordisk chief seeks more deals to cement weight-loss lead amid ‘hype’
...David Moore, vice-president for corporate development, added that the company would focus on acquisitions in diabetes and obesity, ideally in the early stage of development....
March 8, 2024
Equities
Alert: Alphaville LLC issues new research report on Trump Media
...[Enlarge] Further reading:— Alert: Alphaville LLC issues new research report on Duchy of Cornwall (FTAV)— Greenland: Alphaville put on its sellside hat for the deal of the century (FTAV)— Alphaville LLC...
March 26, 2024
Pharmaceuticals sector
Lab monkey prices plunge in China as drug research slows
...Lab monkey prices in China have plummeted as a post-pandemic slowdown in drug development ripples through the pharmaceutical sector in the world’s second-largest economy....
March 1, 2024
Drugs research
UK dementia adviser wants half a million volunteers for clinical trials
...It has pledged to double funding for dementia research to £160mn a year by 2025....
March 20, 2024
FT Live
Global Pharma and Biotech Summit
Driving life sciences innovation in a disrupted world
Tuesday, 5 NovemberIn-Person & Online Conference
Antibiotic resistance
EU approves new antibiotic to tackle rise of superbugs
...Developing new antibiotics is often unattractive for pharmaceutical companies, as research and development costs are high but their use is designed to be limited to reduce the risk of the product driving...
April 22, 2024
Letter
Letter: Don’t make African farmers bear the brunt of EU green policies
...Jodie Keane Senior Research Fellow ODI (Formerly Overseas Development Institute), London SE1, UK...
March 26, 2024
FT Schools
Psychology class: US seeks up to 50-year sentence for FTX founder Sam Bankman-Fried
...One of his most well-known contributions to research is the ‘Sally-Anne task’....
April 21, 2024
LexAstraZeneca PLC
A decade after Pfizer, AstraZeneca needs to find its growth again
...It has 178 prospects at various stages of development; it has been striking a series of deals, including last month’s $2.4bn agreement to buy Canadian biotech Fusion Pharmaceuticals aimed at bolstering its...
April 1, 2024
AstraZeneca PLC
AstraZeneca strikes $2.4bn deal for radiotherapy biotech Fusion
...Susan Galbraith, executive vice-president of oncology research and development at AstraZeneca, said there was an “opportunity to improve” on existing drugs in the area and that the Fusion acquisition would...
March 19, 2024
AstraZeneca PLC
Europe falling behind US and China in pharma innovation, warns AstraZeneca chief
...According to a European Commission analysis of the world’s 2,500 highest spending companies in research and development published in 2023, 12 per cent of leading companies investing in health research are...
April 25, 2024
Roche Holding AG
Roche cuts drug pipeline in effort to revitalise business
...Since the third quarter of 2023 when it had 82 new drugs in development, the company has jettisoned 16 drugs and added 12 others, including the weight-loss drug it gained through its $3.1bn acquisition of...
April 24, 2024
Special ReportThe Americas’ Fastest Growing Companies
Its blockbuster cystic fibrosis treatment costs $300,000 a year. Now Vertex wants to solve the opioid crisis
...So effective is Vertex Pharmaceuticals’ blockbuster cystic fibrosis (CF) drug, Trikafta, that studies project it could extend the lives of some young patients by up to 45 years....
April 26, 2024
Medical science
Prostate cancer test fails to detect some aggressive forms, study shows
...Pointing to the risks of unnecessary treatment, Cancer Research UK said over-diagnosis could have “a negative psychological impact”, and treatment of prostate cancer could also cause physical side effects...
April 6, 2024
FT Live
Infrastructure Investment in Latin America and the Caribbean
Identifying opportunities for investors and asset managers
Wednesday, 12 June237 Park Avenue, New York, NY, USA
Soumaya Keynes
How economists could make themselves more useful
...Gathering more than 600 studies in development economics, she found less than 10 per cent mentioned a policy’s costs. (Policymakers care about prices.)...
April 26, 2024
Disease control and prevention
UK risks missing out on ‘golden age’ of drug discovery, cancer charity warns
...This meant a significant proportion of cancer research was only possible because of public donations, she added....
February 22, 2024
Scientific research
AI explores ‘dark genome’ to shed light on cancer growth
...“They end up being clustered around genes that are altered in cancer in a variety of different ways, providing the first glimpse that these sequences may be key to tumour development,” he said....
March 13, 2024
Drugs research
Diabetes drug offers hope to Parkinson’s sufferers
...The results from the research, which involved 156 people, were a “major breakthrough”, said Olivier Rascol, a Toulouse University Hospital professor and a co-author of the research with Prof Wassilios Meissner...
April 3, 2024
Novo Nordisk AS
Novo Nordisk in €1bn deal for RNA-based heart disease therapies
...Novo Nordisk purchased Dicerna Pharmaceuticals, a company focused in RNA-based therapeutics, for $3.3bn in 2021....
March 25, 2024
UK politics
Watchdog asks Johnson to clarify his relationship with hedge fund
...Johnson’s team have said he had acted as a “diplomatic back channel for the UK”, but the Foreign, Commonwealth and Development Office said he was “not acting on behalf of the UK government”....
March 20, 2024
Camilla Cavendish
Science is closing in on the frailties of old age
...Meanwhile, a trial is looking at whether metformin, commonly prescribed for type 2 diabetes, might delay the development of other chronic diseases....
April 26, 2024
Manica Balasegaram
Antibiotic resistance is the greatest threat to cancer patients
...In contrast, pharmaceutical companies raised just $160mn for antibiotic research, a decline over the decade. Commercial activity and research in antibiotics have been in decline since the 1980s....
February 1, 2024
Dementia
Blood protein test offers ‘reliable’ Alzheimer’s warning 15 years early
...In October, pharmaceuticals companies Eisai and Eli Lilly unveiled research showing the benefits of using new Alzheimer’s drugs very early in the development of the disease....
February 12, 2024
European Organization for Nuclear Research
Succession race begins to lead Cern ‘god particle’ research project
...Thomson is a professor of experimental particle physics at the University of Cambridge and executive chair of the Science and Technology Facilities Council, a UK research organisation....
April 2, 2024

Previous pagePage 1 of 1568Next page